The global Molecular Oncology Market is poised for significant expansion, with a projected valuation of over US$ 7.4 billion by 2034, up from US$ 2.3 billion in 2023, according to the latest industry outlook. The market is expected to register an impressive CAGR of 11.0% between 2024 and 2034, fueled by cutting-edge research, growing cancer prevalence, and increasing adoption of personalized...